SCHEMBL573281

SCHEMBL573281

COC(=O)c1cc([N+](=O)[O-])c(-c2ccccc2)c(S(=O)(=O)N=CN(C)C)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ VCAM1 P19320 1/20 0.45
▸ MAPT P10636 3/20 0.40
▸ GAA P10253 1/20 0.40
▸ ERN1 O75460 2/20 0.39
▸ ACLY P53396 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ THRB P10828 2/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ F2 P00734 1/20 0.37
▸ PRSS1 P07477 1/20 0.37
▸ PRSS2 P07478 1/20 0.37
▸ PRSS3 P35030 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL573280 1.00 VCAM1 (0.45) VCAM1MAPTGAAERN1ACLY
SCHEMBL11000446 0.91 VCAM1 (0.44) VCAM1MAPTGAAERN1ALDH1A1
SCHEMBL11000444 0.91 VCAM1 (0.44) VCAM1MAPTGAAERN1ALDH1A1
SCHEMBL21436486 0.87 VCAM1 (0.43) VCAM1MAPTERN1KDM4EALDH1A1
SCHEMBL21436487 0.87 VCAM1 (0.43) VCAM1MAPTERN1KDM4EALDH1A1
SCHEMBL10222900 0.84 VCAM1 (0.46) VCAM1MAPTGAAALDH1A1CYP1A2
SCHEMBL573657 0.84 VCAM1 (0.46) VCAM1MAPTGAAALDH1A1CYP1A2
SCHEMBL11511671 0.84 VCAM1 (0.43) VCAM1MAPTGAAALDH1A1THRB
SCHEMBL574029 0.84 VCAM1 (0.46) VCAM1MAPTGAAALDH1A1CYP1A2
SCHEMBL21437398 0.83 MAPT (0.43) VCAM1MAPTGAAALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598478-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE Neurotherapeutics Pharma, Inc. (US) 2013-06-05 — — EP disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 — — WO disclosed
Send feedback